Archives Tag: Antonius Schuh
Trovagene’s Urine-based Cancer Detection Technology Validated
April 19, 2022
U.S. Trovagene, Inc. has announced that results emerging from ongoing clinical studies have confirmed the broad applicability of Trovagene technology across a variety of cancer types, and the successful development of a molecular diagnostic test capable of detecting and quantifying oncogene mutations from a simple urine specimen. The ability to regularly detect and monitor the results … Continue reading Trovagene’s Urine-based Cancer Detection Technology Validated
